Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
Specificity Protein 1
100%
Pancreatic Cancer
100%
Ras Activity
100%
Metformin
100%
Epidermal Growth Factor
37%
Mammalian Target of Rapamycin Signaling
37%
RNA Interference
25%
Growth Factors
25%
Insulin-like
25%
Regulated Genes
25%
A1 Receptor
25%
Pancreatic Cancer Cells
25%
Protein Knockdown
25%
Pro-oncogenic
25%
Decreased Expression
12%
Mechanism of Action
12%
Cancer Tumor
12%
Transcription Factor
12%
Ras Signaling
12%
Antidiabetic Drugs
12%
Antineoplastic Agents
12%
Chemopreventive
12%
Oncogenic Pathways
12%
Multiple Cancers
12%
Transcription Factor Proteins
12%
Chemotherapeutic Activity
12%
Transcription Factor Spl
12%
Medicine and Dentistry
Pancreas Cancer
100%
Ras Signaling
100%
Mechanistic Target of Rapamycin
100%
Glycon
100%
Downregulation
37%
Transcription Factor
37%
Epidermal Growth Factor
37%
Carcinogenesis
25%
Cancer Cell
25%
RNA Interference
25%
Somatomedin C Receptor
25%
Proteus Syndrome
12%
Antidiabetic Agent
12%
Antineoplastic Activity
12%
Tumor
12%
Biochemistry, Genetics and Molecular Biology
Mechanistic Target of Rapamycin
100%
Downregulation
75%
Transcription Factor
75%
Epidermal Growth Factor
75%
Cancer Cell
50%
Carcinogenesis
50%
RNA Interference
50%
Insulin-Like Growth Factor 1 Receptor
50%
Antineoplastic Activity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
100%
Mammalian Target of Rapamycin
100%
Metformin
100%
Epidermal Growth Factor
37%
Transcription Factor
37%
Carcinogenesis
25%
Somatomedin C Receptor
25%
Antidiabetic Agent
12%
Multiple Cancer
12%